SPC24 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.652590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.238400E-01
Normal-vs-Stage2
1.370230E-01
Normal-vs-Stage3
4.796200E-01
Normal-vs-Stage4
2.797600E-01
Stage1-vs-Stage2
4.978000E-01
Stage1-vs-Stage3
6.080600E-01
Stage1-vs-Stage4
7.817600E-01
Stage2-vs-Stage3
2.288400E-01
Stage2-vs-Stage4
3.641200E-01
Stage3-vs-Stage4
6.800400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.633630E-01
Normal-vs-AfricanAmerican
2.454800E-01
Normal-vs-Asian
1.940160E-01
Caucasian-vs-AfricanAmerican
4.631200E-01
Caucasian-vs-Asian
9.172400E-01
AfricanAmerican-vs-Asian
4.780000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.944500E-02
Normal-vs-Female
2.383800E-01
Male-vs-Female
8.577600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.245200E-01
Normal-vs-Age(41-60Yrs)
2.011000E-01
Normal-vs-Age(61-80Yrs)
1.461560E-01
Normal-vs-Age(81-100Yrs)
2.115200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.889000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.626800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.060000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.283200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.408600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.867400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.944250E-01
Normal-vs-Daily Drinker
7.386400E-02
Normal-vs-Weekly Drinker
2.997200E-01
Normal-vs-Occasional Drinker
1.829220E-01
Normal-vs-Social Drinker
1.082610E-01
Non Drinker-vs-Daily Drinker
9.022600E-01
Non Drinker-vs-Weekly Drinker
5.921000E-01
Non Drinker-vs-Occasional Drinker
8.802800E-01
Non Drinker-vs-Social Drinker
4.450600E-01
Daily Drinker-vs-Weekly Drinker
6.297400E-01
Daily Drinker-vs-Occasional Drinker
7.721800E-01
Daily Drinker-vs-Social Drinker
4.573000E-01
Weekly Drinker-vs-Occasional Drinker
5.397400E-01
Weekly Drinker-vs-Social Drinker
9.808400E-01
Occasional Drinker-vs-Social Drinker
3.897000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.514200E-01
Normal-vs-Grade 2
6.209200E-01
Normal-vs-Grade 3
6.789200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.0756000001777E-07
Grade 1-vs-Grade 3
4.21129999761405E-08
Grade 1-vs-Grade 4
5.514200E-01
Grade 2-vs-Grade 3
1.588210E-02
Grade 2-vs-Grade 4
6.209200E-01
Grade 3-vs-Grade 4
6.789200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.919790E-01
Normal-vs-NonDiabetic
1.496010E-01
Diabetic-vs-NonDiabetic
9.704200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.935400E-03
Normal-vs-NoPancreatitis
1.923430E-01
Pancreatitis-vs-NoPancreatitis
2.144500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.051840E-01
Normal-vs-N1
1.812980E-01
N0-vs-N1
8.367600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.605300E-04
Normal-vs-TP53-NonMutant
1.942360E-01
TP53-Mutant-vs-TP53-NonMutant
3.07789999998143E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
